Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Assets (2023 - 2025)

Zhengye Biotechnology Holding has reported Current Assets over the past 3 years, most recently at $19.4 million for Q4 2025.

  • Quarterly Current Assets fell 21.62% to $19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.4 million through Dec 2025, down 21.62% year-over-year, with the annual reading at $19.6 million for FY2025, 19.23% down from the prior year.
  • Current Assets was $19.4 million for Q4 2025 at Zhengye Biotechnology Holding, down from $28.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $28.1 million in Q2 2025 and troughed at $19.4 million in Q4 2025.
  • The 3-year median for Current Assets is $25.5 million (2024), against an average of $24.6 million.
  • Year-over-year, Current Assets fell 5.95% in 2024 and then fell 21.62% in 2025.
  • A 3-year view of Current Assets shows it stood at $26.3 million in 2023, then fell by 5.95% to $24.7 million in 2024, then dropped by 21.62% to $19.4 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Current Assets are $19.4 million (Q4 2025), $28.1 million (Q2 2025), and $24.7 million (Q4 2024).